Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
The journal of nutrition, health & aging
Published in: The journal of nutrition, health & aging 6/2018

01-06-2018

Berberine Improves Cognitive Deficiency and Muscular Dysfunction via Activation of the AMPK/SIRT1/PGC-1a Pathway in Skeletal Muscle from Naturally Aging Rats

Authors: Y. Yu, Y. Zhao, F. Teng, J. Li, Y. Guan, J. Xu, X. Lv, F. Guan, Ming Zhang, L. Chen

Published in: The journal of nutrition, health & aging | Issue 6/2018

Login to get access

Abstract

Objective

The manifestations of aging include cognitive deficits and muscular dysfunction, which are closely linked to impairment of mitochondrial biogenesis. Berberine, an isoquinoline alkaloid, presents multiple anti-diabetic pharmacological effects. Evidence has indicated that insulin resistance and cognitive impairment share the same pathogenesis, and berberine could reverse glucose metabolism abnormalities and muscle mitochondrial dysfunction induced by a high-fat diet. This study was used to investigate whether berberine could be used as an anti-aging drug to prevent cognitive deficits and muscular dysfunction in natural aging.

Methods

Biochemical indicators and an intraperitoneal glucose tolerance test were tested in 5-monthold rats (5 mo group), 24-month-old rats (24 mo group) and 24-month-old rats that had undergone 6 months of berberine treatment (BBR group). A Morris water maze test was conducted to assess the cognitive ability of the rats. Insulin resistance in whole-body was evaluated by intraperitoneal glucose tolerance test (IPGTT). The morphology of the skeletal muscle tissue was observed by hematoxylin-eosin (HE) staining. The levels of total cholesterol, triglyceride, ATP and reactive oxygen species (ROS) were assessed with corresponding reagent kits. The protein expressions of GLUT4, AMPK, SIRT1 and PGC-1α in skeletal muscle were examined by Western blot.

Results

The results showed that administration of berberine for 6 months significantly improved cognitive deficits and insulin resistance in naturally aging rats (p<0.01). Furthermore, berberine treatment helped normalize the disordered alignment and the decreased number of muscle fibers (p<0.01) in the skeletal muscle of 24 mo rats. Berberine decreased the levels of ROS in both the serum and the skeletal muscle of 24 mo rats (p<0.01). Berberine increased the protein expression of p-AMPK, SIRT1 and PGC-1α and increased the production of ATP in the skeletal muscle of aging rats (p<0.01).

Conclusions

Berberine markedly ameliorates aging-related reductions in cognitive ability and muscular function, and the activation of the AMPK/SIRT1/PGC-1α pathway in skeletal muscle may be the underlying protective mechanism of berberine on muscular function.
Literature
1.
2.
Fischer L, Baker J, Rienhoff R, Strauss B, Tirp J, Busch D, Schorer J: Perceptualcognitive expertise of handball coaches in their young and middle adult years. J Sports Sci 2016, 34(17):1637–1642.CrossRefPubMed
3.
4.
Purves-Smith FM, Sgarioto N, Hepple RT: Fiber typing in aging muscle. Exerc Sport Sci Rev 2014, 42(2):45–52.CrossRefPubMed
5.
Scott D, Park MS, Kim TN, Ryu JY, Hong HC, Yoo HJ, Baik SH, Jones G, Choi KM: Associations of Low Muscle Mass and the Metabolic Syndrome in Caucasian and Asian Middle-aged and Older Adults. J Nutr Health Aging 2016, 20(3):248–255.CrossRefPubMed
6.
Groen BB, Hamer HM, Snijders T, van Kranenburg J, Frijns D, Vink H, van Loon LJ: Skeletal muscle capillary density and microvascular function are compromised with aging and type 2 diabetes. J Appl Physiol (1985) 2014, 116(8):998–1005.CrossRef
7.
Maddison LA, Joest KE, Kammeyer RM, Chen W: Skeletal muscle insulin resistance in zebrafish induces alterations in beta-cell number and glucose tolerance in an ageand diet-dependent manner. Am J Physiol Endocrinol Metab 2015, 308(8):E662–669.CrossRefPubMedPubMedCentral
8.
Morris JK, Vidoni ED, Honea RA, Burns JM, Alzheimer’s Disease Neuroimaging I: Impaired glycemia increases disease progression in mild cognitive impairment. Neurobiol Aging 2014, 35(3):585–589.CrossRefPubMed
9.
Kim TE, Lee DH, Kim YJ, Mok JO, Kim CH, Park JH, Lee TK, Yoo K, Jeong Y, Lee Y et al: The relationship between cognitive performance and insulin resistance in non-diabetic patients with mild cognitive impairment. Int J Geriatr Psychiatry 2015, 30(6):551–557.CrossRefPubMed
10.
Chistiakov DA, Sobenin IA, Revin VV, Orekhov AN, Bobryshev YV: Mitochondrial aging and age-related dysfunction of mitochondria. Biomed Res Int 2014, 2014:238463.PubMedPubMedCentral
11.
De Fronzo RA, Gunnarsson R, Bjorkman O, Olsson M, Wahren J: Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus. J Clin Invest 1985, 76(1):149–155.CrossRef
12.
Sandri M, Lin J, Handschin C, Yang W, Arany ZP, Lecker SH, Goldberg AL, Spiegelman BM: PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription. Proc Natl Acad Sci U S A 2006, 103(44):16260–16265.CrossRefPubMedPubMedCentral
13.
Loprinzi PD: Epidemiological investigation of muscle-strengthening activities and cognitive function among older adults. Chronic Illn 2016, 12(2):157–162.CrossRefPubMed
14.
15.
Lan F, Cacicedo JM, Ruderman N, Ido Y: SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1. Possible role in AMP-activated protein kinase activation. J Biol Chem 2008, 283(41):27628–27635.CrossRefPubMedPubMedCentral
16.
Gerhart-Hines Z, Rodgers JT, Bare O, Lerin C, Kim SH, Mostoslavsky R, Alt FW, Wu Z, Puigserver P: Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alpha. EMBO J 2007, 26(7):1913–1923.CrossRefPubMedPubMedCentral
17.
Lan J, Zhao Y, Dong F, Yan Z, Zheng W, Fan J, Sun G: Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension. J Ethnopharmacol 2015, 161: 69–81.CrossRefPubMed
18.
Zhang Q, Li Y, Chen L: [Effect of berberine in treating type 2 diabetes mellitus and complications and its relevant mechanisms]. Zhongguo Zhong Yao Za Zhi 2015, 40(9):1660–1665.PubMed
19.
Zhang Z, Li X, Li F, An L: Berberine alleviates postoperative cognitive dysfunction by suppressing neuroinflammation in aged mice. Int Immunopharmacol 2016, 38: 426–433.CrossRefPubMed
20.
Durairajan SS, Liu LF, Lu JH, Chen LL, Yuan Q, Chung SK, Huang L, Li XS, Huang JD, Li M: Berberine ameliorates beta-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer’s disease transgenic mouse model. Neurobiol Aging 2012, 33(12):2903–2919.CrossRefPubMed
21.
Zhang M, Lv X, Li J, Meng Z, Wang Q, Chang W, Li W, Chen L, Liu Y: Sodium caprate augments the hypoglycemic effect of berberine via AMPK in inhibiting hepatic gluconeogenesis. Mol Cell Endocrinol 2012, 363(1-2):122–130.CrossRefPubMedPubMedCentral
22.
Gomes AP, Duarte FV, Nunes P, Hubbard BP, Teodoro JS, Varela AT, Jones JG, Sinclair DA, Palmeira CM, Rolo AP: Berberine protects against high fat diet-induced dysfunction in muscle mitochondria by inducing SIRT1-dependent mitochondrial biogenesis. Biochim Biophys Acta 2012, 1822(2):185–195.CrossRefPubMed
23.
Deibel SH, Zelinski EL, Keeley RJ, Kovalchuk O, McDonald RJ: Epigenetic alterations in the suprachiasmatic nucleus and hippocampus contribute to age-related cognitive decline. Oncotarget 2015, 6(27):23181–23203.CrossRefPubMedPubMedCentral
24.
Lin CH, Wu RM: Biomarkers of cognitive decline in Parkinson’s disease. Parkinsonism Relat Disord 2015, 21(5):431–443.CrossRefPubMed
25.
Lo RY, Jagust WJ, Alzheimer’s Disease Neuroimaging I: Effect of cognitive reserve markers on Alzheimer pathologic progression. Alzheimer Dis Assoc Disord 2013, 27(4):343–350.CrossRefPubMed
26.
Kullmann S, Heni M, Hallschmid M, Fritsche A, Preissl H, Haring HU: Brain Insulin Resistance at the Crossroads of Metabolic and Cognitive Disorders in Humans. Physiol Rev 2016, 96(4):1169–1209.CrossRefPubMed
27.
Capiotti KM, De Moraes DA, Menezes FP, Kist LW, Bogo MR, Da Silva RS: Hyperglycemia induces memory impairment linked to increased acetylcholinesterase activity in zebrafish (Danio rerio). Behav Brain Res 2014, 274: 319–325.CrossRefPubMed
28.
Perez-Rubio KG, Gonzalez-Ortiz M, Martinez-Abundis E, Robles-Cervantes JA, Espinel-Bermudez MC: Effect of berberine administration on metabolic syndrome, insulin sensitivity, and insulin secretion. Metab Syndr Relat Disord 2013, 11(5):366–369.CrossRefPubMed
29.
Chen Q, Mo R, Wu N, Zou X, Shi C, Gong J, Li J, Fang K, Wang D, Yang D et al: Berberine Ameliorates Diabetes-Associated Cognitive Decline through Modulation of Aberrant Inflammation Response and Insulin Signaling Pathway in DM Rats. Front Pharmacol 2017, 8:334.CrossRefPubMedPubMedCentral
30.
Xue H, Ji Y, Wei S, Yu Y, Yan X, Liu S, Zhang M, Yao F, Lan X, Chen L: HGSD attenuates neuronal apoptosis through enhancing neuronal autophagy in the brain of diabetic mice: The role of AMP-activated protein kinase. Life Sci 2016, 153: 23–34.CrossRefPubMed
31.
Calvo-Ochoa E, Arias C: Cellular and metabolic alterations in the hippocampus caused by insulin signalling dysfunction and its association with cognitive impairment during aging and Alzheimer’s disease: studies in animal models. Diabetes Metab Res Rev 2015, 31(1):1–13.CrossRefPubMed
32.
Kim B, Feldman EL: Insulin resistance as a key link for the increased risk of cognitive impairment in the metabolic syndrome. Exp Mol Med 2015, 47:e149.CrossRefPubMedPubMedCentral
33.
Yin Q, Ma Y, Hong Y, Hou X, Chen J, Shen C, Sun M, Shang Y, Dong S, Zeng Z et al: Lycopene attenuates insulin signaling deficits, oxidative stress, neuroinflammation, and cognitive impairment in fructose-drinking insulin resistant rats. Neuropharmacology 2014, 86: 389–396.CrossRefPubMed
34.
Gao N, Zhao TY, Li XJ: The protective effect of berberine on beta-cell lipoapoptosis. J Endocrinol Invest 2011, 34(2):124–130.CrossRefPubMed
35.
Yang TC, Chao HF, Shi LS, Chang TC, Lin HC, Chang WL: Alkaloids from Coptis chinensis root promote glucose uptake in C2C12 myotubes. Fitoterapia 2014, 93: 239–244.CrossRefPubMed
36.
Xia X, Yan J, Shen Y, Tang K, Yin J, Zhang Y, Yang D, Liang H, Ye J, Weng J: Berberine improves glucose metabolism in diabetic rats by inhibition of hepatic gluconeogenesis. PLoS One 2011, 6(2):e16556.CrossRefPubMedPubMedCentral
37.
Pirillo A, Catapano AL: Berberine, a plant alkaloid with lipid- and glucoselowering properties: From in vitro evidence to clinical studies. Atherosclerosis 2015, 243(2):449–461.CrossRefPubMed
38.
Potes Y, de Luxan-Delgado B, Rodriguez-Gonzalez S, Guimaraes MRM, Solano JJ, Fernandez-Fernandez M, Bermudez M, Boga JA, Vega-Naredo I, Coto-Montes A: Overweight in elderly people induces impaired autophagy in skeletal muscle. Free Radic Biol Med 2017, 110: 31–41.CrossRefPubMed
39.
Kenny HC, Rudwill F, Breen L, Salanova M, Blottner D, Heise T, Heer M, Blanc S, O’Gorman DJ: Bed rest and resistive vibration exercise unveil novel links between skeletal muscle mitochondrial function and insulin resistance. Diabetologia 2017.
40.
Zhang N, Valentine JM, Zhou Y, Li ME, Zhang Y, Bhattacharya A, Walsh ME, Fischer KE, Austad SN, Osmulski P et al: Sustained NFkappaB inhibition improves insulin sensitivity but is detrimental to muscle health. Aging Cell 2017.
41.
Ou YC, Chuang HH, Li WC, Tzeng IS, Chen JY: Gender difference in the association between lower muscle mass and metabolic syndrome independent of insulin resistance in a middle-aged and elderly Taiwanese population. Arch Gerontol Geriatr 2017, 72: 12–18.CrossRefPubMed
42.
Brown M, Ross TP, Holloszy JO: Effects of ageing and exercise on soleus and extensor digitorum longus muscles of female rats. Mech Ageing Dev 1992, 63(1):69–77.CrossRefPubMed
43.
Crescenzo R, Bianco F, Mazzoli A, Giacco A, Liverini G, Iossa S: Skeletal muscle mitochondrial energetic efficiency and aging. Int J Mol Sci 2015, 16(5):10674–10685.CrossRefPubMedPubMedCentral
44.
Javadov S, Jang S, Rodriguez-Reyes N, Rodriguez-Zayas AE, Soto Hernandez J, Krainz T, Wipf P, Frontera W: Mitochondria-targeted antioxidant preserves contractile properties and mitochondrial function of skeletal muscle in aged rats. Oncotarget 2015, 6(37):39469–39481.CrossRefPubMedPubMedCentral
45.
Yamamori T, Yasui H, Yamazumi M, Wada Y, Nakamura Y, Nakamura H, Inanami O: Ionizing radiation induces mitochondrial reactive oxygen species production accompanied by upregulation of mitochondrial electron transport chain function and mitochondrial content under control of the cell cycle checkpoint. Free Radic Biol Med 2012, 53(2):260–270.CrossRefPubMed
46.
Bagkos G, Koufopoulos K, Piperi C: ATP synthesis revisited: new avenues for the management of mitochondrial diseases. Curr Pharm Des 2014, 20(28):4570–4579.CrossRefPubMed
47.
Russ DW, Acksel C, McCorkle KW, Edens NK, Garvey SM: Effects of Running Wheel Activity and Dietary HMB and beta-alanine Co-Supplementation on Muscle Quality in Aged Male Rats. J Nutr Health Aging 2017, 21(5):554–561.CrossRefPubMed
48.
Gurd BJ: Deacetylation of PGC-1alpha by SIRT1: importance for skeletal muscle function and exercise-induced mitochondrial biogenesis. Appl Physiol Nutr Metab 2011, 36(5):589–597.CrossRefPubMed
49.
Park SJ, Ahmad F, Philp A, Baar K, Williams T, Luo H, Ke H, Rehmann H, Taussig R, Brown AL et al: Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell 2012, 148(3):421–433.CrossRefPubMedPubMedCentral
50.
Jager S, Handschin C, St-Pierre J, Spiegelman BM: AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. Proc Natl Acad Sci U S A 2007, 104(29):12017–12022.CrossRefPubMedPubMedCentral
51.
Iwabu M, Yamauchi T, Okada-Iwabu M, Sato K, Nakagawa T, Funata M, Yamaguchi M, Namiki S, Nakayama R, Tabata M et al: Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca(2+) and AMPK/SIRT1. Nature 2010, 464(7293):1313–1319.CrossRefPubMed
Metadata
Title
Berberine Improves Cognitive Deficiency and Muscular Dysfunction via Activation of the AMPK/SIRT1/PGC-1a Pathway in Skeletal Muscle from Naturally Aging Rats
Authors
Y. Yu
Y. Zhao
F. Teng
J. Li
Y. Guan
J. Xu
X. Lv
F. Guan
Ming Zhang
L. Chen
Publication date
01-06-2018
Publisher
Springer Paris
Published in
The journal of nutrition, health & aging / Issue 6/2018
Print ISSN: 1279-7707
Electronic ISSN: 1760-4788
DOI
https://doi.org/10.1007/s12603-018-1015-7

Other articles of this Issue 6/2018

The journal of nutrition, health & aging 6/2018 Go to the issue

OriginalPaper

Links between Atherosclerosis and Osteoporosis in Middle Aged and Elderly Men

OriginalPaper

Mediterranean Diet and Musculoskeletal-Functional Outcomes in Community-Dwelling Older People: A Systematic Review and Meta-Analysis

OriginalPaper

Associations between Plasmatic Polyunsaturated Fatty Acids Concentrations and Cognitive Status and Decline in Neurocognitive Disorders

OriginalPaper

Role of Oral Nutritional Supplements Enriched with B-hydroxy-B-Methylbutyrate in Maintaining Muscle Function and Improving Clinical Outcomes in Various Clinical Settings

OriginalPaper

Effect of a Minimal-Massive Intervention in Hospitalized Older Patients with Oropharyngeal Dysphagia: A Proof of Concept Study

OriginalPaper

Glucagon-Like Peptide-2 Improve Intestinal Mucosal Barrier Function in Aged Rats
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits